Summary:
The current study defines the incidence and clinical manifestations of hyperacute graft-versus-host disease (haGVHD; fever, skin rash, diarrhea, and hepatic dysfunction) and analyzes the risk factor and the impact of haGVHD on the results of allogeneic stem cell transplantation (SCT). In all, 90 patients underwent allogeneic SCT from 71 matched siblings or 19 alternative donors. Immediate high-dose steroids were administered to 22 patients who met the criteria. The overall incidence of haGVHD was 36.7% (n=34) and haGVHD was also strongly correlated with acute (aGVHD) (P<0.001) and extensive chronic GVHD (cGVHD) (P=0.007), and found to be associated with decreased probability of relapse (P=0.0017). Early intervention with steroids within 7 days after the diagnosis of haGVHD might be associated with better survival. A survival analysis of the overall survival and disease-free survival did not reveal any difference between haGVHD+ and haGVHD− groups. In multivariate analysis, the use of an alternative donor (P=0.020) was identified as the only risk factor. Immediate high-dose steroids were effective in treating haGVHD. We conclude that in an allogeneic setting, haGVHD is not an uncommon manifestation, associated with the development of aGVHD or cGVHD. The only risk factor for haGVHD was the use of an alternative donor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sullivan KM, Deeg HJ, Sanders J et al. Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986; 67: 1172–1175.
Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898.
Lee CK, Gingrich RD, Hohl RJ et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175–182.
Cahill RA, Spitzer TR, Mazumder A . Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996; 18: 177–184.
Colvin GA, Lambert J-F, Lum LG et al. The Haplo-Immunostorm Syndrome: a new clinical entity observed in minimal immunotherapy with outpatient haploidentical bone marrow transplantation. Blood 2002; 100: 411a.
Choi SJ, Lee KH, Lee JH et al. Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: a retrospective review of 216 patients. Bone Marrow Transplant 2003; 32: 809–813.
Huang X, Chen Y, Guo N et al. Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases. Zhonghua Yi Xue Za Zhi 2002; 82: 511–514.
Tanaka Y, Kami M, Ogawa S et al. Hyperacute graft-versus-host disease and NKT cells. Am J Hematol 2000; 63: 60–61.
Maiolino A, Biasoli I, Lima J et al. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393–397.
Horn TD . Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol 1994; 21: 385–392.
Takatsuka H, Takemoto Y, Yamada S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419–426.
Nurnberger W, Willers R, Burdach S et al. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 1997; 74: 221–224.
Elmaagacli AH, Basoglu S, Peceny R et al. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood 2002; 99: 1130–1135.
Pan L, Teshima T, Hill GR et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999; 93: 4071–4078.
Reddy V, Hill GR, Pan L et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 2000; 69: 691–693.
Acknowledgements
We thank Dr Thomas R Spitzer (Department of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA) for his careful review and critical advice for this paper. The great work of our nursing staff is also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, D., Sohn, S., Kim, J. et al. Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 33, 1025–1030 (2004). https://doi.org/10.1038/sj.bmt.1704479
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704479
Keywords
This article is cited by
-
Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
American Journal of Clinical Dermatology (2019)
-
Engraftment syndrome: double-edged sword of hematopoietic cell transplants
Bone Marrow Transplantation (2015)
-
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset
Bone Marrow Transplantation (2010)
-
Hyperacute GVHD and emergence of peripheral CD3+CD56+ T cells and activated natural killer cells are useful markers for early diagnosis of post-transplant hemophagocytic syndrome
Bone Marrow Transplantation (2005)